atomoxetine hydrochloride has been researched along with Seizures in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, HJ; Niu, J; Tan, Z; Zhang, R | 1 |
| Cheng, Y; Lu, H; Ma, HX; Shen, Y; Sun, JL; Zhang, HH; Zhao, HT | 1 |
| Feng, HJ; Zhang, H; Zhao, H | 1 |
| Cotten, JF; Feng, HJ; Long, X; Zhao, H | 1 |
| Buchanan, GF; Dayton, KG; Kruse, SW; Purnell, BS; Rosner, JI | 1 |
| Bodmer, M; Ceschi, A; Monte, AA | 1 |
| Holdridge, KC; Hornbuckle, K; Johannes, CB; McAfee, AT; Walker, AM | 1 |
| Araki, H; Kawasaki, H; Suemaru, K; Takechi, K | 1 |
| Karila, L | 1 |
| Acharya, N; Bangs, ME; Hornbuckle, K; Jones, M; Landon, J; McAfee, AT; Wong, J | 1 |
| Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E | 1 |
| Daviss, SR; Sawant, S | 1 |
| Lintner, CP; Spiller, HA; Winter, ML | 1 |
| Kashani, J; Ruha, AM | 1 |
| Allen, AJ; Ball, S; Bangs, ME; Dunn, D; Edison, T; Holdridge, KC; Jin, L; Wernicke, JF; Zhang, S | 1 |
1 review(s) available for atomoxetine hydrochloride and Seizures
| Article | Year |
|---|---|
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Size; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clonidine; Dextroamphetamine; Growth Disorders; Guanfacine; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Substance-Related Disorders; Suicide Prevention; Tic Disorders; Treatment Outcome | 2013 |
14 other study(ies) available for atomoxetine hydrochloride and Seizures
| Article | Year |
|---|---|
Adrenergic α2 receptors are implicated in seizure-induced respiratory arrest in DBA/1 mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Atomoxetine Hydrochloride; Clonidine; Imidazoles; Mice, Inbred DBA; Receptors, Adrenergic, alpha-2; Respiration; Seizures | 2021 |
Central deficiency of norepinephrine synthesis and norepinephrinergic neurotransmission contributes to seizure-induced respiratory arrest.
Topics: Acoustic Stimulation; Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Brain Stem; Brain Waves; Disease Models, Animal; Female; Male; Mice, Inbred DBA; Norepinephrine; Pentylenetetrazole; Prazosin; Receptors, Adrenergic, alpha-1; Respiration; Respiration, Artificial; Respiratory Insufficiency; Seizures; Signal Transduction; Sudden Unexpected Death in Epilepsy; Tyrosine 3-Monooxygenase | 2021 |
Atomoxetine, a norepinephrine reuptake inhibitor, reduces seizure-induced respiratory arrest.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Death, Sudden; Disease Models, Animal; Mice; Mice, Inbred DBA; Norepinephrine; Respiration Disorders; Seizures | 2017 |
The effect of atomoxetine, a selective norepinephrine reuptake inhibitor, on respiratory arrest and cardiorespiratory function in the DBA/1 mouse model of SUDEP.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Animals; Anticonvulsants; Atomoxetine Hydrochloride; Blood Pressure; Brugada Syndrome; Cardiovascular Agents; Disease Models, Animal; Epilepsy; Female; Heart Rate; Male; Mice, Inbred DBA; Respiration; Respiratory System Agents; Seizures | 2017 |
Effect of monoamine reuptake inhibition and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Duloxetine Hydrochloride; Electroshock; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Reboxetine; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Sudden Unexpected Death in Epilepsy | 2019 |
Safety of non-therapeutic atomoxetine exposures--a national poison data system study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Atomoxetine Hydrochloride; Child; Child, Preschool; Databases, Factual; Female; Follow-Up Studies; Humans; Infant; Male; Middle Aged; Poison Control Centers; Propylamines; Retrospective Studies; Seizures; Suicide, Attempted; United States; Young Adult | 2013 |
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Consumer Product Safety; Databases as Topic; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Insurance Claim Reporting; Logistic Models; Male; Odds Ratio; Propylamines; Retrospective Studies; Risk Assessment; Risk Factors; Seizures; United States | 2008 |
Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Bupropion; Depression; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Norepinephrine Plasma Membrane Transport Proteins; Pentylenetetrazole; Propylamines; Seizures; Swimming | 2011 |
[Atomoxetine in ADHD: caution].
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Cognition; Humans; Methylphenidate; Motor Activity; Propylamines; Randomized Controlled Trials as Topic; Seizures; Treatment Failure; Treatment Outcome | 2011 |
A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cohort Studies; Female; Humans; Male; Propylamines; Retrospective Studies; Risk; Seizures | 2013 |
Seizures and prolonged QTc with atomoxetine overdose.
Topics: Adolescent; Antipsychotic Agents; Atomoxetine Hydrochloride; Depressive Disorder, Major; Drug Overdose; Humans; Long QT Syndrome; Male; Propylamines; Seizures | 2004 |
Atomoxetine ingestions in children: a report from poison centers.
Topics: Adolescent; Atomoxetine Hydrochloride; Charcoal; Child; Child, Preschool; Dose-Response Relationship, Drug; Emergency Treatment; Female; Humans; Hypertension; Infant; Male; Poison Control Centers; Propylamines; Seizures; Self Administration; Suicide, Attempted; Tachycardia | 2005 |
Isolated atomoxetine overdose resulting in seizure.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Drug Overdose; Female; Humans; Propylamines; Seizures; Suicide, Attempted; Tachycardia, Sinus | 2007 |
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Databases, Factual; Female; Humans; Male; Meta-Analysis as Topic; Methylphenidate; Product Surveillance, Postmarketing; Propylamines; Risk; Seizures | 2007 |